Skip to content

ELOXX PHARMACEUTICALS, INC.: filings

Every ELOXX PHARMACEUTICALS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 52 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-11fiscal Q2 202625750001193125-26-344964
10-Q2026-05-05fiscal Q1 202625530001193125-26-204722
10-K2026-03-17fiscal FY 2025401190001193125-26-108687
10-Q2023-11-13fiscal Q3 202333960000950170-23-062940
10-Q2023-08-11fiscal Q2 202333910000950170-23-041837
10-Q2023-05-12fiscal Q1 202334700000950170-23-021821
10-K2023-03-31fiscal FY 202239770000950170-23-011360
10-Q2022-11-10fiscal Q3 2022351000000950170-22-024490
10-Q2022-08-12fiscal Q2 202235940001564590-22-029339
10-Q2022-05-06fiscal Q1 202230600001564590-22-018586
10-K2022-03-30fiscal FY 202138910001564590-22-012683
10-Q2021-11-08fiscal Q3 202134890001564590-21-055313
10-Q2021-08-16fiscal Q2 202134860001564590-21-044626
10-Q2021-05-07fiscal Q1 202132640001564590-21-025356
10-K2021-03-12fiscal FY 202041970001564590-21-012703
10-Q2020-11-06fiscal Q3 202036950001564590-20-051711
10-Q2020-08-07fiscal Q2 202036920001564590-20-038092
10-Q2020-05-08fiscal Q1 202035700001564590-20-023543
10-K2020-03-06fiscal FY 201942950001564590-20-009148
10-Q2019-11-06fiscal Q3 201935910001564590-19-041002
10-Q2019-08-07fiscal Q2 201935870001564590-19-029697
10-Q2019-05-09fiscal Q1 201936680001564590-19-017648
10-K2019-03-14fiscal FY 201833810001564590-19-007811
10-Q2018-11-08fiscal Q3 201828720001564590-18-028309
10-Q2018-08-10fiscal Q2 201827710001564590-18-021183
10-Q2018-05-10fiscal Q1 201825510001193125-18-159256
10-K2018-03-16fiscal FY 201728740001193125-18-086028
10-Q2017-11-14fiscal Q1 201827570001144204-17-059104
10-K2017-10-13fiscal FY 201729730001144204-17-052475
10-Q2017-05-22fiscal Q3 201726720001144204-17-028931
10-Q2017-02-10fiscal Q2 201726720001144204-17-007403
10-Q2016-11-14fiscal Q1 201725520001144204-16-134343
10-K2016-10-13fiscal FY 201633810001144204-16-128038
10-Q2016-05-12fiscal Q3 201626720001144204-16-101221
10-Q2016-02-16fiscal Q2 201624640001144204-16-082378
10-Q2015-11-16fiscal Q1 201623480001144204-15-065800
10-K2015-10-09fiscal FY 201531780001144204-15-058919
10-Q2015-05-14fiscal Q3 201525700001144204-15-030595
10-Q2015-02-17fiscal Q2 201526700001144204-15-010034
10-Q2014-11-14fiscal Q1 201528580001144204-14-068712
10-K2014-09-29fiscal FY 201433840001144204-14-058176
10-Q2014-05-09fiscal Q3 201427840001144204-14-029005
10-Q2014-02-14fiscal Q2 201426830001144204-14-009665
10-Q2013-11-14fiscal Q1 201427680001144204-13-061794
10-K2013-09-11fiscal FY 2013311190001144204-13-050259
10-Q2013-05-15fiscal Q3 201327850001144204-13-029119
10-Q2013-02-14fiscal Q2 201325780001144204-13-008524
10-Q2012-11-14fiscal Q1 201326620001144204-12-062352
10-K/A2012-10-26fiscal FY 2012311140001144204-12-057875
10-Q2012-05-14fiscal Q3 201226750001144204-12-028430
10-Q2012-02-14fiscal Q2 201226770001144204-12-008203
10-Q2011-11-14fiscal Q1 201226620001144204-11-063847

Inspect the source

Entity
ELOXX PHARMACEUTICALS, INC. / CIK 0001035354
Captured
2026-09-20T05:15:09.498Z
SEC response SHA-256
b351a9ed06ee3e6f1d738bbdb3852b866526fe561e11a7ffd4a81bc43bb27195

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001035354.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))